Pacira BioSciences, Inc. (PCRX) — Defensive Interval Ratio
Pacira BioSciences, Inc. (PCRX) has a Defensive Interval Ratio of 616 days as of March 2026. Defensive assets of $183.51 Million (cash $-, short-term investments $57.87 Million, receivables $125.64 Million) cover 616 days of daily cash needs of $298.05K/day. See PCRX net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Pacira BioSciences, Inc. Defensive Interval Ratio (2008–2025)
This chart shows how Pacira BioSciences, Inc.'s Defensive Interval Ratio has evolved across 18 annual periods from 2008 to 2025. As of March 2026, the ratio stands at 616 days, meaning defensive assets of $183.51 Million can fund 616 days of operations without new revenue. See Pacira BioSciences, Inc. balance sheet quality to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Pacira BioSciences, Inc. (2008–2025)
The table below presents the year-by-year Defensive Interval Ratio for Pacira BioSciences, Inc. from 2008 to 2025, covering 18 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see PCRX market cap overview.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 617 days | $203.95 Million | $330.38K/day | $- | $79.88 Million | ▲ +239 days |
| 2024 | 378 days | $321.14 Million | $849.10K/day | $- | $207.84 Million | ▼ -487 days |
| 2023 | 865 days | $230.84 Million | $266.80K/day | $- | $125.28 Million | ▲ +166 days |
| 2022 | 699 days | $282.91 Million | $404.86K/day | $- | $184.51 Million | ▲ +582 days |
| 2021 | 117 days | $167.15 Million | $1.43 Million/day | $- | $70.83 Million | ▼ -567 days |
| 2020 | 684 days | $474.75 Million | $694.05K/day | $- | $421.70 Million | ▼ -202 days |
| 2019 | 886 days | $261.25 Million | $294.99K/day | $- | $213.72 Million | ▼ -853 days |
| 2018 | 1738 days | $288.93 Million | $166.19K/day | $- | $250.93 Million | ▼ -137 days |
| 2017 | 1876 days | $288.88 Million | $154.02K/day | $- | $257.22 Million | ▲ +519 days |
| 2016 | 1356 days | $166.59 Million | $122.84K/day | $- | $136.65 Million | ▲ +1048 days |
| 2015 | 308 days | $127.84 Million | $415.55K/day | $- | $101.98 Million | ▼ -61 days |
| 2014 | 369 days | $141.50 Million | $383.59K/day | $- | $119.14 Million | ▲ +147 days |
| 2013 | 222 days | $74.23 Million | $334.09K/day | $- | $59.64 Million | ▼ -687 days |
| 2012 | 910 days | $35.28 Million | $38.78K/day | $- | $30.92 Million | ▲ +542 days |
| 2011 | 367 days | $32.10 Million | $87.43K/day | $- | $29.98 Million | ▲ +311 days |
| 2010 | 56 days | $2.50 Million | $44.72K/day | $- | $1.31 Million | ▼ -12 days |
| 2009 | 68 days | $2.67 Million | $39.50K/day | $- | $1.22 Million | ▼ -13 days |
| 2008 | 81 days | $3.77 Million | $46.62K/day | $- | $1.18 Million | — |